[1] |
杨敏捷,罗剑钧,刘清欣, 等. 125I粒子条剂量分布研究[J]. 介入放射学杂志, 2015, 24(1): 59-63.
|
[2] |
戴真煜,姚立正,李文会, 等. 经皮胆道支架联合支架旁125I粒子条植入治疗恶性胆道梗阻[J]. 介入放射学杂志, 2011, 20(9): 706-708.
|
[3] |
黄兢姚,杨维竹,江娜, 等. 125I粒子条胆道支架治疗恶性胆道梗阻38例[J]. 介入放射学杂志, 2014, 23(7): 633-636.
|
[4] |
姜浩,赵辉,赵苏鸣, 等. 胆道支架及胆道支架联合125I粒子条植入治疗胆管癌伴阻塞性黄疸疗效评估[J]. 中国临床研究, 2015, 28(11): 1425-1428.
|
[5] |
黄兢姚,杨维竹,江娜, 等. 经皮胆道支架联合支架内外粒子植入治疗胰头癌伴胆道梗阻[J]. 临床放射学杂志, 2015, 34(4): 629-633.
|
[6] |
Ma J,Luo J,Gu J, et al. Malignant obstructive jaundice treated with intraluminal placement of Iodine-125 seed strands and metal stents: An analysis of long-term outcomes and prognostic features[J]. Brachytherapy, 2018, 17(4): 689-695.
|
[7] |
张媛媛,马玉红,张福新. 胆道支架联合125I粒子植入治疗恶性梗阻性黄疸临床效果分析[J]. 中国现代普通外科进展, 2017, 20(2): 100-104.
|
[8] |
姚红响,陈根生,叶冠雄, 等. 单纯胆道支架与125I粒子支架腔内照射治疗恶性梗阻性黄疸[J]. 中华肝胆外科杂志, 2014, 20(12): 869-872.
|
[9] |
岳彦波. 125I粒子条联合胆道支架植入治疗恶性梗阻性黄疸的临床疗效分析[J]. 中外医疗, 2016, 35(21): 49-50.
|
[10] |
尹晓翔,王志学,沈松鹤,朱鸷翔,吴涛.胆道支架联合125I粒子条置入治疗恶性阻塞性黄疸疗效分析[J]. 中国实用医药, 2015, (26): 94-95.
|
[11] |
尹晓翔,王志学,沈松鹤, 等. 裸支架与裸支架联合125I粒子条治疗恶性梗阻性黄疸疗效对比分析[J]. 中国现代药物应用, 2015, 9(18): 75-76.
|
[12] |
潘恒.新型胆道引流管的设计与临床应用研究[D]. 福建医科大学,2013.
|
[13] |
姚红响,陈根生,叶冠雄, 等. 胆道支架联合125I粒子条治疗恶性梗阻性黄疸[J].介入放射学杂志, 2014, 23(10): 893-896.
|
[14] |
刘明强,庄少鹉,刘丽莎.胆道支架联合125I粒子条置入治疗恶性胆道梗阻效果分析[J]. 福建医药杂志, 2016, 38(6): 28-30.
|
[15] |
韩成龙,马亦龙,欧盛秋, 等. 125I粒子条联合胆道支架植入治疗恶性梗阻性黄疸22例疗效分析[J]. 介入放射学杂志, 2015, 24(2): 141-145.
|
[16] |
罗剑钧. 腔内近距离放疗联合及支架植入治疗恶性胆道梗阻[J]. 介入放射学杂志, 2015, (3): 215-218.
|
[17] |
Jiao D,Wu G,Ren J, et al. Study of self-expandable metallic stent placement intraluminal 125I seed strands brachytherapy of malignant biliary obstruction[J]. Surg Endosc, 2017, 31(12): 4996-5005.
|
[18] |
黄兢姚,杨维竹,江娜, 等. 经皮胆道支架联合支架内外125I粒子植入治疗肝门部胆管癌研究[J]. 临床放射学杂志, 2016, 35(3): 448-452.
|
[19] |
陈涛,朱晓黎,王万胜, 等. 125I粒子植入内照射治疗肝内胆管细胞癌疗效及安全性的初步分析[J]. 医学影像学杂志, 2017, 27(7): 1276-1280.
|
[20] |
Yang M,Yan Z,Luo J, et al. A pilot study of intraluminal brachytherapy using 125I seed strand for locally advanced pancreatic ductal adenocarcinoma with obstructive jaundice[J]. Brachytherapy, 2016, 15(6): 859-864.
|
[21] |
Zhang W,Yang ZQ,Shi HB, et al. Placement of 125I seed strands and stents for a type IV Klatskin tumor[J]. World J Gastroenterol, 2015, 21(1): 373-376.
|
[22] |
Zhang W,Luo J,Liu Q, et al. Brachytherapy with Iodine-125 seeds strand for treatment of main portal vein tumor thrombi: an experimental study in a rabbit model[J]. Am J Cancer Res, 2016, 6(3): 587-599.
|
[23] |
李说,颜志平,张雯, 等. 兔门静脉主干内植入连续排列125I粒子条的实验研究[J]. 介入放射学杂志, 2009, 18(8): 607-611.
|
[24] |
王叙馥. 125Ⅰ粒子组织间植入治疗兔VX2移植性肝癌及对肝脏辐射损伤的实验研究[D]. 山东大学,2012.
|
[25] |
毛晓楠,卢再鸣,郭启勇.门静脉支架联合125I粒子条植入治疗门脉癌栓12例[J]. 介入放射学杂志, 2016, 25(12): 1058-1064.
|
[26] |
刘清欣,颜志平,李说, 等.125I粒子条联合门静脉支架及化疗栓塞治疗原发性肝癌合并门静脉癌栓[J]. 介入放射学杂志, 2009, 18(8): 593-595.
|
[27] |
王晓维,付守忠,戴锋, 等. 门静脉支架及125I粒子条植入联合肝动脉栓塞化疗术治疗原发性肝细胞肝癌伴门静脉癌栓的效果观察[J]. 南通大学学报(医学版), 2016, 36(4): 305-308.
|
[28] |
李说. 连续线状排列125I粒子条联合金属支架+TACE治疗肝癌门静脉主干癌栓实验及临床研究[D]. 复旦大学,2009.
|
[29] |
吴林霖,罗剑钧,颜志平, 等. 门静脉支架及经动脉药物治疗栓塞联合或未联合血管内植入碘-125粒子条治疗肝癌合并门静脉主干癌栓的比较[J]. 中华肝脏病杂志, 2012, 20(12): 915-919.
|
[30] |
吴林霖,颜志平,张雯, 等. 经动脉灌注化疗联合125I粒子条治疗原发性肝癌合并门脉癌栓的疗效分析[J].介入放射学杂志, 2015, 24(9): 776-780.
|
[31] |
余天柱,罗剑钧,颜志平. 血管内近程放疗与序贯三维适形放疗治疗门静脉主干癌栓的疗效对比[J]. 介入放射学杂志, 2017, 26(9): 787-792.
|
[32] |
Tan T,Xiao Y,Zhou S, et al. Y-configuration stent combined with iodine-125 seeds strand for the treatment of hepatocellular carcinoma with tumor thrombosis in portal vein branches: A case report[J]. Medicine(Baltimore), 2017, 96(46): e8660.
|
[33] |
Yao LH,Su L,Liu L, et al. Stenting of the portal vein combined with different numbers of iodine-125 seed strands: Dosimetric analyses[J]. Chin Med J(Engl), 2017, 130(18): 2183-2189.
|
[34] |
Sun JH,Zhou T,Zhu T, et al. Portal vein stenting combined with iodine-125 seeds endovascular implantation followed by transcatheter arterial chemoembolization for treatment of hepatocellular carcinoma patients with portal vein tumor thrombus[J]. Biomed Res Int, 2016, 2016: 3048261.
|
[35] |
李文会,戴真煜,万豪光, 等.125I粒子条联合门静脉支架及TACE序贯索拉菲尼治疗肝癌合并门静脉主干癌栓[J].中华医学杂志, 2016, 96(23): 1838-1842.
|
[36] |
武京鹏,何东风. 125I粒子条植入治疗原发性肝癌伴门静脉主干癌栓的近期疗效[J/CD]. 中华介入放射学电子杂志, 2015, 3(3): 144-147.
|
[37] |
Yang M,Fang Z,Yan Z, et al. Transarterialchemoembolisation (TACE)combined with endovascular implantation of an iodine-125 seed strand for the treatment of hepatocellular carcinoma with portal vein tumor thrombosis versus TACE alone: a two-arm, randomised clinical trial[J]. J Cancer Res Clin Oncol, 2014, 140(2): 211-219.
|
[38] |
Luo J,Yan Z,Liu Q, et al. Endovascular placement of iodine-125 seed strand and stent combined with chemoembolization for treatment of hepatocellular carcinoma with tumor thrombus in main portal vein[J]. J Vasc Interv Radiol, 2011, 22(4): 479-489.
|
[39] |
涂文辉,罗剑钧,刘清欣, 等. 原发性肝癌伴门静脉主干癌栓患者存活超5年1例并文献复习[J]. 介入放射学杂志, 2015, 24(12): 1101-1106.
|
[40] |
Zhang ZH,Zhang W,Gu JY, et al. Treatment of hepatocellular carcinoma with tumor thrombus with the use of iodine-125 seed strand implantation and transarterial chemoembolization: A propensity-score analysis[J]. J Vasc Interv Radiol, 2018, 29(8): 1085-1093.
|
[41] |
Luo JJ,Zhang ZH,Liu QX, et al. Endovascular brachytherapy combined with stent placement and TACE for treatment of HCC with main portal vein tumor thrombus[J]. Hepatol Int, 2016, 10(1): 185-195.
|
[42] |
Zhang W,Yan Z,Luo J, et al. Iodine-125 seeds strand for treatment of tumor thrombus in inferior vena cava: an experimental study in a rabbit model[J]. Cardiovasc Intervent Radiol, 2013, 36(5): 1371-1382.
|
[43] |
郝红军,张兴仕,金鑫, 等.支架联合125I粒子条植入治疗肝癌所致下腔静脉恶性梗阻20例[J]. 介入放射学杂志, 2016, 25(6): 538-542.
|
[44] |
杨清慧,张雯,颜志平, 等. 植入放射性支架联合经动脉化疗栓塞(TACE)治疗肝恶性肿瘤合并下腔静脉(IVC)梗阻[J]. 复旦学报(医学版), 2014, 41(5): 617-623.
|
[45] |
张雯. 线状排列125I粒子条及金属支架联合TACE治疗肝癌伴下腔静脉恶性梗阻的实验与临床研究[D]. 复旦大学,2010.
|
[46] |
Gong M,Song J,He X, et al. Intraluminal brachytherapy using a self-expandable stent loaded with linear iodine-125 seeds in a patient with reiterative recurrence of cancer-associated vein obstruction: A case report with 3 months of follow-up[J]. Vasc Endovascular Surg, 2018, 52(6): 463-468.
|
[47] |
Li W,Dai Z,Yao L, et al. Chemoembolization and stenting combined with iodine-125 seed strands for the treatment of hepatocellular carcinoma with inferior vena cava obstruction[J]. Exp Ther Med, 2015, 10(3): 973-977.
|